Sorafenib for hepatocellular carcinoma according to Child-Pugh class of liver function.

MLA

Farinati, Fabio, et al. “Sorafenib for Hepatocellular Carcinoma According to Child-Pugh Class of Liver Function.” Cancer Chemotherapy and Pharmacology, vol. 68, no. 6, Dec. 2011, pp. 1639–40. EBSCOhost, https://doi.org/10.1007/s00280-011-1776-8.

APA

Farinati, F., Giacomin, A., & Vanin, V. (2011). Sorafenib for hepatocellular carcinoma according to Child-Pugh class of liver function. Cancer Chemotherapy and Pharmacology, 68(6), 1639–1640. https://doi.org/10.1007/s00280-011-1776-8

Chicago

Farinati, Fabio, Anna Giacomin, and Veronica Vanin. 2011. “Sorafenib for Hepatocellular Carcinoma According to Child-Pugh Class of Liver Function.” Cancer Chemotherapy and Pharmacology 68 (6): 1639–40. doi:10.1007/s00280-011-1776-8.